Anti-ageing Drugs Market 2020: Deep Analysis of Current Trends and Opportunities by Top Key Players are Research Report, 2025
The global Anti-Ageing
Drugs Market Is set to witness huge growth potential in the coming years
owing to rising awareness among the aging population regarding the use of
anti-aging products. The industry however is in its infancy stage due to lot of
skepticism regarding the cellular understanding of ageing process. On the other
hand, the industry is also witnessing a large amount of research and
development activities with drug manufacturers showing an increased focus
towards significantly decreasing the impact of ageing and ultimately increasing
the lifespan.
Various recent discoveries indicating the use of
pharmacology to delay and possibly improve the aging process has spurred the
interest of many manufacturers. Aging is a natural process in a human life.
However, such discoveries should contribute in increasing the life span of older
people as well as maintain their quality of life. The introduction of such anti
ageing drugs will lead to the reduction of socio-economic burden in developed
countries particularly. Citing this, research and development of anti ageing
drugs is on forefront in the developed countries of North America and
Europe.
Get Sample Copy of This Premium Report @
https://brandessenceresearch.com/requestSample/PostId/450
The global Anti-ageing Drugs Market is witnessing a
huge surge in research activities of biotechnology companies towards
development of drugs to extend normal human lifespan. For instance, Elevian,
Inc. is actively conducting research focused on a protein called growth
differentiating factor 11 (GDF11). This protein is found to improve brain
function, exercise capacity and fasten muscle repair process when introduced in
old mice.
Moreover, Elysium Health, one of the prominent
players in the anti-aging market space has introduced an over the counter
nutritional supplement that intends to boost one’s NAD+ levels leading to
enhance longevity genes. However, clinical benefit of this supplement is not
yet proven.
Increasing target population and growing
influence of lifestyle industry are some of the pivotal factors boosting the
market growth.
The rising ageing population acts as target market
for anti-ageing drugs driving the growth of this market. According to the World
Health Organization (WHO), the proportion of global population over age of 60
years is predicted to double and reach 22% by 2050 from 12% in 2015. Moreover,
the growing influence of lifestyle and fashion industry has led to an increased
desire among the old to stay young and healthy. Apart from this, the elevating
level of beauty standards has led to boost in demand for anti-ageing drugs
among all age groups. Rising investments in research and development activities
leading to incessant launch of new products is anticipated to be another
pivotal factor driving the anti-ageing drugs market growth during the forecast
period.
North America accounted for the largest
share in Anti-Ageing Drugs Market
Developed economies of U.S. and Canada are the
largest revenue contributors to the global anti-ageing drugs market. This
should be well justified by the high living standards, huge paying capacity and
growing influence of fashion and lifestyle industry among the population.
Moreover, the region houses developed infrastructure for carrying out
progressive research activities aimed towards development of new anti-ageing
products. These factors have collectively led to the expansion of anti-ageing
drugs market in the region. Europe is set to witness similar trends as that of
North America and grab the second position in the global anti-ageing drugs
market. While the growing personal care industry coupled with increasing
awareness regarding use of anti-ageing products in the emerging economies of
China and India is expected to propel the Asia Pacific anti-ageing drugs market
growth in the years to come.
Key Players in Anti-Ageing Drugs Market
Some of the major players operating in Global
Anti-Ageing Drugs Market include Galderma, Sanofi, Allergan, Daewoong
Pharmaceutical, MMJ PhytoTech, Revitacare, Merz Pharma, SciVision Biotech,
Canbex Therapeutics, Sun Pharmaceuticals, Nu Skin, L’ORÉAL, Elysium Health
Inc., and BIOTIME, INC. among others.
Global Anti-Ageing Drugs market is segmented by
type, drug class, and application. The Global Anti-Ageing Drugs market by type
includes injectable, oral, and topical, while based on drug class the industry
is segmented into antioxidants and enzymes, serums and supplements, and stem
cells. By application market segmentation includes skin, hair, muscles,
age-related disorders and others.
The geographic analysis in the report spans across
North America, Europe, Asia-Pacific and Rest of the World. Further, country
level analysis of the Global Anti-Ageing Drugs Market includes U.S., Mexico,
Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia,
Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, and Africa among others.
Market Segmentation: -
By Type:
Injectable
Oral
Topical
By Drug Class:
Antioxidants and enzymes
Serums and supplements
Stem cells
By Application:
Skin
Hair
Muscles
Age-related disorders
Others
By Region & Country:
North America
US.
Canada
Europe
UK.
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Comments
Post a Comment